Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

A Danish study highlights the increased risk of heart attack and ischemic stroke associated with certain hormonal ...

When it comes to testing for sexually transmitted infections (STIs), many young adults prefer the privacy and conv ...

Some hormonal contraceptives are associated with a small but significant increased risk of stroke and heart attack ...

A Danish study has highlighted the risk of using certain hormonal contraceptives, especially hormone-based combination pills, ...

From a pool of over 2 million women of reproductive age, users of most methods of hormonal contraception -- including ...

A compound found in the skin of grapes, blueberries and raspberries has the potential to improve female fertility, research ...

The female reproductive system includes internal and external organs, each designed to carry out varying functions. Learn more about the anatomy of this system.